Factors influencing biased agonism in recombinant cells expressing the human α1A -adrenoceptor.
Edilson Dantas da Silva JuniorMasaaki SatoJon MerlinNatalie BroxtonDana S HutchinsonSabatino VenturaBronwyn A EvansRoger J SummersPublished in: British journal of pharmacology (2017)
We have shown that while adrenergic agonists display bias at human α1A -adrenoceptors, the marked bias of oxymetazoline for ERK1/2 phosphorylation originates from off-target effects. Commonly used cell lines express a repertoire of endogenous GPCRs that may confound studies on biased agonism at recombinant receptors.